Ablation of Least Shrew Central Neurokinin NK 1 Receptors Reduces GR73632-Induced Vomiting

Behavioral Neuroscience

Volumn 123, Issue 3, 2009, Pages 701-706

  Ray, Andrew P ^a   Chebolu, Seetha ^a   Ramirez, Juan ^a   Darmani, Nissar A ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

emesis; solitary tract nucleus; stable substance P saporin; tachykinin; vagus

Indexed keywords

5 AMINOVALERYLSUBSTANCE P [7-11][9 PROLINE 10 (N METHYLLEUCINE)]; NEUROKININ 1 RECEPTOR; SAPORIN; SUBSTANCE P; TACHYKININ;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG BIOAVAILABILITY; NERVE CELL NETWORK; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; SCRATCHING; SHREW; SOLITARY TRACT NUCLEUS; VOMITING;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN STEM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; INTESTINE, SMALL; MYENTERIC PLEXUS; PEPTIDE FRAGMENTS; PHOTOMICROGRAPHY; RECEPTORS, NEUROKININ-1; RIBOSOME INACTIVATING PROTEINS, TYPE 1; SHREWS; SUBSTANCE P; VOMITING;

EID: 66349119971     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0015733     Document Type: Article

References (42)

1. Andrews P.L., Okada F., Woods A.J., Hagiwara H., Kakaimoto S., Toyoda M., and Matsuki N. The emetic and anti-emetic effects of the capsaicin analogue resiniferatoxin in Suncus murinus, the house musk shrew. British Journal of Pharmacology 130 (2000) 1247-1254
2. 1 receptor in nausea and emesis. In: Holzer P. (Ed). Tachykinins: Handbook of experimental pharmacology 164 (2004), Springer-Verlag, Berlin 359-440
3. Carpenter D.O., Briggs D.B., and Strominger N. Behavioral and electrophysiological studies of peptide-induced emesis in dogs. Federation Proceedings 43 (1984) 2952-2954
4. Chappa A.K., Audus K.L., and Lundte S.M. Characteristics of substance P transport across the blood-brain barrier. Pharmaceutical Research 23 (2006) 1201-1208
5. Cubeddu L.X., Hoffmann I.S., Fuenmayor N.T., and Malave J.J. Changes in serotonin metabolism in cancer patients: Its relationship to nausea and vomiting induced by chemotherapeutic drugs. British Journal of Cancer 66 (1992) 198-203
6. Darmani N.A. Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: A new experimental model of emesis. Journal of Neural Transmission 105 (1998) 1143-1154
7. Darmani N.A., Crim J.L., Janoyan J.J., Abad J., and Ramirez J. A re-evaluation of the neurotransmitter basis of chemotherapy-induced immediate and delayed vomiting: Evidence from the least shrew. Brain Research 1248 (2009) 40-58
8. Darmani N.A., and Johnson J.C. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis. European Journal of Pharmacology 488 (2004) 201-212
9. Darmani N.A., Mock O.B., Towns L.C., and Gerdes C.F. The head-twitch response in the least shrew (Cryptotis parva) is a 5-HT2- and not a 5-HT1C-mediated phenomenon. Pharmacology, Biochemistry, and Behavior 48 (1994) 383-396
10. Darmani N.A., Wang Y., Abad J., Ray A.P., Thrush G.R., and Ramirez J. Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK(1) receptor antagonists. Brain Research 1214 (2008) 58-72
11. Darmani N.A., Zhao W., and Ahmad B. The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew). Journal of Neural Transmission 106 (1999) 1045-1061
12. Elliott P.J., Mason G.S., Graham E.A., Turpin M.P., and Hagan R.M. Modulation of the rat mesolimbic dopamine pathway by neurokinins. Behavioural Brain Research 51 (1992) 77-82
13. Fone K.C., Johnson J.V., Bennett G.W., and Marsden C.A. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats. British Journal of Pharmacology 96 (1989) 599-608
14. Freed A.L., Audus K.L., and Lundte S.M. Investigation of substance P transport across the blood-brain barrier. Peptides 23 (2002) 157-165
15. Gardner C.J., Bountra C., Bunce K.T., Dale T.J., Jordan C.C., et al. Antiemetic activity of neurokinin receptor antagonists is mediated centrally in the ferret. British Journal of Pharmacology 112 (1994) 516
16. Hawthorn J., Ostler K.J., and Andrews P.L. The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret. Quarterly Journal of Experimental Physiology 73 (1988) 7-21
17. Hesketh P.J. Chemotherapy induced nausea and vomiting. New England Journal of Medicine 358 (2008) 2482-2494
18. Hesketh P.J., Van Belle S., Aapro M., Tattersall F.D., Naylor R.J., Hargreaves R., et al. Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. European Journal of Cancer 39 (2003) 1074-1080
19. Holzer P., and Holzer-Petsche U. Tachykinins in the gut. Part I: Expression, release and motor function. Pharmacology and Therapeutics 73 (1997) 173-217
20. Holzer P., and Holzer-Petsche U. Tachykinins in the gut. Part II: Roles in neural excitation, secretion and inflammation. Pharmacology and Therapeutics 73 (1997) 219-263
21. Ito C., Isobe Y., Kijima H., Kiuchi Y., Ohtsuki H., Kawamura R., et al. The anti-emetic activity of GK-128 in Suncus murinus. European Journal of Pharmacology 285 (1995) 37-43
22. Ito H., Nishibayashi M., Kawabata K., Maeda S., Seki M., and Ebukuro S. Induction of Fos protein in neurons in the medulla oblongata after motion- and X-irradiation-induced emesis in musk shrews (Suncus murinus). Autonomic Neuroscience 107 (2003) 1-8
23. Jordan K., Schmoll H.J., and Aapro M.S. Comparative activity of antiemetic drugs. Critical Reviews in Oncology/Hematology 61 (2007) 162-175
24. Kan K.K., Jones R.L., Ngan M.P., and Rudd J.A. Actions of prostanoids to induce emesis and defecation in the ferret. European Journal of Pharmacology 453 (2002) 299-308
25. Mazzone S.B., and Geraghty D.P. Characterization and regulation of tachykinin receptors in the nucleus tractus solitarius. Clinical and Experimental Pharmacology and Physiology 27 (2000) 939-942
26. Miller A.D., and Ruggiero D.A. Emetic reflex arc revealed by expression of the immediate-early gene c-fos in the cat. Journal of Neuroscience 14 (1994) 871-888
27. 1 receptor antagonist, in the ferret. European Journal of Pharmacology 363 (1998) 49-55
28. 3 receptors. European Journal of Pharmacology 428 (2001) 215-220
29. Nattie E., and Li A. Neurokinin-1 receptor-expressing neurons in the ventral medulla are essential for normal central and peripheral chemoreception in the conscious rat. Journal of Applied Physiology 101 (2006) 1596-1606
30. Ravard S., Betschart J., Fardin V., Flamand O., and Blanchard J.C. Differential ability of tachykinin NK-1 and NK-2 agonists to produce scratching and grooming behaviours in mice. Brain Research 651 (1994) 199-208
31. Ray A.P., and Darmani N.A. A histologically derived stereotaxic atlas and substance P immunohistochemistry in the brain of the least shrew (Cryptotis parva) support its role as a model organism for behavioral and pharmacological research. Brain Research 1156 (2007) 99-111
32. Reynolds D.J., Barber N.A., Grahame-Smith D.G., and Leslie R.A. Cisplatin-evoked induction of c-fos protein in the brainstem of the ferret: The effect of cervical vagotomy and the anti-emetic 5-HT3 receptor antagonist granisetron (BRL 43694). Brain Research 565 (1991) 231-236
33. Roila F., and Fatigoni S. New antiemetic drugs. Annals of Oncology 17 Suppl. 2 (2006) 96-100
34. Rupniak N.M., Tattersall F.D., Williams A.R., Rycroft W., Carlson E.J., Cascieri M.A., et al. In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists. European Journal of Pharmacology 326 (1997) 201-209
35. Thor K.B., and Helke C.J. Serotonin and substance P colocalization in medullary projections to the nucleus tractus solitarius: Dual-colour immunohistochemistry combined with retrograde tracing. Journal of Chemical Neuroanatomy 2 (1989) 139-148
36. Travagli R.A., Hermann G.E., Browning K.N., and Rogers R.C. Brainstem circuits regulating gastric function. Annual Review of Physiology 68 (2006) 279-305
37. Van Sickle M.D., Oland L.D., Mackie K., Davison J.S., and Sharkey K.A. Delta-9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets. American Journal of Physiology: Gastrointestinal and Liver Physiology 285 (2003) 566-576
38. Veyrat-Follet C., Farinotti R., and Palmer J.L. Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds. Drugs 53 (1997) 206-234
39. Wang L., Martinez V., Kimura H., and Tache Y. 5-Hydroxytryptophan activates colonic myenteric neurons and propulsive motor function through 5-HT4 receptors in conscious mice. American Journal of Physiology: Gastrointestinal and Liver Physiology 292 (2007) 419-428
40. Wiley R.G., and Lappi D.A. Targeting neurokinin-1 receptor-expressing neurons with [Sar9,Met(O2)11] substance P-saporin. Neuroscience Letters 277 (1999) 1-4
41. Willins D.L., and Meltzer H.Y. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. Journal of Pharmacology and Experimental Therapeutics 282 (1997) 699-706
42. Yip J., and Chahl L.A. Localization of NK1 and NK3 receptors in guinea-pig brain. Regulatory Peptides 98 (2001) 55-62